RadiDoseControl Portfolio | Acquisition Opportunity

RadiDoseControl Portfolio

A defensible, system-level patent portfolio enabling precise control over how radiation is delivered inside the human body across modern oncology procedures.

Strategic Acquisition Opportunity

Developed by Dr. Mark D'Andrea

This portfolio controls the delivery layer of radiation therapy. In a field where precision defines outcomes, ownership of how radiation is deployed is no longer optional. It is strategic.

United States Patent Assets

US 8,979,725 Brachytherapy device that improves internal radiation placement.
US 9,320,915 Expanded protection for tandem and ovoid implantation techniques.
US 9,149,653 Devices enhancing internal therapeutic radiation delivery.
US 9,192,345 Systems supporting diagnosis and targeted radiation treatment.
US 9,604,074 Radiation sheet technology controlling dose distribution.
US 10,207,127 Extended protection for radiation sheet systems.
US 10,086,213 Balloon-based device for minimally invasive radiation delivery.

International Coverage

CA 2,874,228 Brachytherapy implantation systems for Canadian market.
CA 2,902,707 Pending radiation delivery method improvements.
CA 2,904,896 Pending radiation diagnosis and treatment systems.
CA 2,846,715 Pending radiation sheet technology.
MX/a/2015/011519 Allowed therapeutic radiation delivery systems.
MX/a/2015/011524 Pending radiation diagnosis systems.
MX/a/2014/003102 Allowed radiation sheet technology.

RadiDoseControl™ represents a rare opportunity to acquire control over a critical layer of oncology treatment infrastructure.